Novartis AG at UBS Global Healthcare Conference (Virtual) Transcript
Good morning, everyone. Welcome to the last day of the UBS Global Healthcare Conference. Thank you for being with us. My name is Laura Sutcliffe. I cover Novartis here at UBS, and I'm delighted to be joined by Susanne Schaffert, who's the CEO of Novartis Oncology.
We've got about 40 minutes. I will ask Susanne to kick off with some opening remarks, which I don't think will take very long, and then we'll jump into Q&A. I have some prepared, but if you'd like to ask a question yourself, you can do that via the webcast. If that's not working for you, you can always drop me an e-mail, [email protected]. And we'll try to get through as many of them as we can.
So with that, I will hand you to Susanne for a few opening comments.
Thank you so much, Laura, and thanks, everybody, for joining. So let me give a few introductory remarks, and then we get right into the Q&A.
So we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |